MedPath

Ofloxacin

PRESCRIBING INFORMATION Rx Only Ofloxacin Ophthalmic Solution, USP 0.3% STERILE OPHTHALMIC SOLUTION

Approved
Approval ID

cd01954d-918b-456a-e053-2995a90a859c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 17, 2023

Manufacturers
FDA

NuCare Pharmaceuticaals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ofloxacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-2544
Application NumberANDA076513
Product Classification
M
Marketing Category
C73584
G
Generic Name
ofloxacin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJuly 17, 2023
FDA Product Classification

INGREDIENTS (6)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
OFLOXACINActive
Quantity: 3 mg in 1 mL
Code: A4P49JAZ9H
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ofloxacin - FDA Drug Approval Details